E3 PreliminaryModerate confidencePEM unclearObservationalPeer-reviewedMachine draft
Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome.
Jerjes, Walid K, Taylor, Norman F, Wood, Peter J et al. · Psychoneuroendocrinology · 2007 · DOI
Quick Summary
This study tested how the bodies of ME/CFS patients respond to a small dose of a steroid medication called prednisolone. Researchers found that people with ME/CFS showed a stronger suppression of cortisol (a stress hormone) after taking the medication compared to healthy controls, suggesting their bodies may be overly sensitive to this type of feedback signal from the steroid.
Why It Matters
Understanding how the HPA axis functions differently in ME/CFS patients may help explain some core symptoms like fatigue and post-exertional malaise. This research contributes to the growing evidence that ME/CFS involves measurable biological abnormalities in hormone regulation rather than being primarily psychological.
Observed Findings
- Baseline salivary cortisol levels were significantly lower in CFS subjects compared to controls
- Both salivary cortisol and urinary cortisol metabolites showed significantly greater suppression in CFS subjects post-prednisolone dose
- Mean percentage suppression of cortisol measures was significantly higher in CFS compared to controls
- Urinary cortisol metabolites were lower in CFS subjects pre-prednisolone, though this did not reach statistical significance
Inferred Conclusions
- The HPA axis in CFS patients demonstrates enhanced sensitivity to negative feedback control as demonstrated by the prednisolone suppression test
- Alterations in HPA axis control mechanisms are present in patients with established CFS
- Prednisolone may be a more physiologically appropriate tool than dexamethasone for detecting subtle degrees of glucocorticoid sensitivity in CFS
Remaining Questions
- Does this enhanced feedback sensitivity contribute to or result from CFS pathology, or is it an epiphenomenon?
- How does this HPA axis abnormality relate to other observed CFS abnormalities such as immune dysregulation or mitochondrial dysfunction?
- Do CFS patients with different symptom profiles or disease severity levels show different degrees of prednisolone sensitivity?
What This Study Does Not Prove
This study does not prove that enhanced HPA axis feedback sensitivity causes ME/CFS symptoms or that it is the primary driver of the disease. It also does not establish whether this finding is specific to ME/CFS or occurs in other fatiguing illnesses, and it cannot explain whether this represents a beneficial adaptation or a pathological change.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Small SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →